Details

Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč : doktorska disertacija
ID Koren, Ana (Author), ID Čufer, Tanja (Mentor) More about this mentor... This link opens in a new window, ID Korošec, Peter (Comentor)

.pdfPDF - Presentation file, Download (2,09 MB)
MD5: A9F73324DEF993114265803B781F0EBD
PID: 20.500.12556/rul/d6454d84-3e5f-43c0-a05f-848327dd79a0

Language:Slovenian
Keywords:onkologija, nedrobnocelični karcinom pljuč, matične celice novotvorb, epitelno-mezenhimski prehod, prognoza, cirkulirajoče celice novotvorb, biološki tumorski označevalci
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:MF - Faculty of Medicine
Place of publishing:Ljubljana
Publisher:[A. Koren]
Year:2016
Number of pages:XVI, 93 str.
PID:20.500.12556/RUL-84295 This link opens in a new window
UDC:616.24-006(043.3)
COBISS.SI-ID:284476416 This link opens in a new window
Publication date in RUL:29.07.2016
Views:4000
Downloads:1044
Metadata:XML DC-XML DC-RDF
:
KOREN, Ana, 2016, Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč : doktorska disertacija [online]. Doctoral dissertation. Ljubljana : A. Koren. [Accessed 31 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=84295
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:The importance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer : doctoral dissertation
Keywords:oncology, carcinoma non-small-cell lung, neoplastic stem cells, epithelial-mesenchymal transition, prognosis, neoplastic cells circulating, biomarkers tumor

Similar documents

Similar works from RUL:
  1. Pregled zdravljenja bolnikov z napredovalnim nedrobnoceličnim pljučnim rakom z mutacijami v receptorju za epidermalni rastni dejavnik med leti 2010 in 2014 na Univerzitetni kliniki Golnik
  2. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  3. Raziskava možnosti racionalizacije režima odmerjanja pembrolizumaba pri zdravljenju napredovalega nedrobnoceličnega raka pljuč
Similar works from other Slovenian collections:
  1. Pomen mutacije gena receptorja za epidermalni rastni dejavnik za zdravljenje nedrobnoceličnega raka pljuč
  2. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  3. Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
  4. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  5. Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer: a retrospective chart review study (REFLECT)

Back